Please use this identifier to cite or link to this item:
|Title:||Immunopathology of progressive subretinal fibrosis: A variant of sympathetic ophthalmia||Authors:||Lim, W.-K.
|Issue Date:||Sep-2004||Citation:||Lim, W.-K., Chee, S.-P., Sng, I., Nussenblatt, R.B., Chan, C.-C. (2004-09). Immunopathology of progressive subretinal fibrosis: A variant of sympathetic ophthalmia. American Journal of Ophthalmology 138 (3) : 475-477. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ajo.2004.04.013||Abstract:||Purpose We report the immunopathology of progressive subretinal fibrosis, a variant of sympathetic ophthalmia. Design Brief case report. Method Review of medical record and immunopathology of a chorioretinal biopsy of a 40-year-old man who presented with left total retinal detachment (RD) following multiple vitrectomies in the right eye for RD. Small peripherally retinal holes, snow banks, and inflammatory nodules along the ora serrata were observed during left vitrectomy. Both eyes deteriorated rapidly to blindness with progressive subretinal fibrosis and inflammation over 3 months, and the patient was unresponsive to systemic prednisolone and azathioprine. Result Immunopathology of the chorioretinal biopsy of the right eye revealed aggregates of CD20+ B cells, surrounded by CD3+ T cells. CD68+ macrophages were scattered throughout. Conclusion The rapid clinical course described in this case may be related to the unique immunopathology of rapidly forming peudogerminal centers in the choroids and retina. © 2004 by Elsevier Inc. All rights reserved.||Source Title:||American Journal of Ophthalmology||URI:||http://scholarbank.nus.edu.sg/handle/10635/133043||ISSN:||00029394||DOI:||10.1016/j.ajo.2004.04.013|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Nov 30, 2022
WEB OF SCIENCETM
checked on Nov 22, 2022
checked on Dec 1, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.